An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy

Eye

Volumn 23, Issue 8, 2009, Pages 1668-1674

  Schwartz, G F ^a   Plake, K S ^b   Mychaskiw, M A ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PFIZER INC   (United States)

Author keywords

Adherence; Compliance; Glaucoma; Ocular hypotensive medication

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BLURRED VISION; EYE DISEASE; FACE VALIDITY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; SCORING SYSTEM;

AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; FEMALE; GLAUCOMA; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MODELS, THEORETICAL; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 69049083739     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.337     Document Type: Article

References (49)

1. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701-713.
2. Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 1993; 116: 176-181. (Pubitemid 23229078)
3. Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 2005; 112: 953-961.
4. Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 2005; 140: 598-606.
5. Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health 1993; 83: 711-716.
6. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with pharmacotherapy in the management of glaucoma. Eur J Ophthalmol 2003; 13(Suppl 4): S44-S52.
7. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study. Clin Ther 2003; 25: 1172-1185. (Pubitemid 36532585)
8. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004; 137(1 Suppl): S3-S12. (Pubitemid 38091629)
9. Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol 2005; 16: 114-121.
10. Schwartz GF, Reardon G, Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol 2004; 137(1 Suppl): S13-S16. (Pubitemid 38091630)
11. Sackett DL. Introduction. In: Sackett DL, Haynes RB (eds). Compliance with Therapeutic Regimens. Johns Hopkins University Press: Baltimore, 1976, pp 1-6.
12. Schwartz GF. Measuring persistency with drug therapy in glaucoma management. Am J Manag Care 2002; 8(Suppl): S237-S239. (Pubitemid 34918723)
13. Janis IL, Mann L. Decision Making: A Psychological Analysis of Conflict, Choice and Commitment. Free Press: New York, 1977.
14. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84: 191-215.
15. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390-395.
16. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol 1992; 47: 1102-1114.
17. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997; 12: 38-48.
18. Cancer Prevention Research Center. Transtheoretical model. Available at: http://www.uri.edu/research/cprc/transtheoretical.htm. Accessed 8 January, 2008.
19. Tsai JC, McClure CA, Ramos SE, Schlundt PG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma 2003; 12: 393-398.
20. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 1998; 116: 1496-1504. (Pubitemid 28520671)
21. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119: 1050-1058. (Pubitemid 32652197)
22. Horne R. The Medication Adherence Report Scale. University of Brighton Press: Brighton, England, 2004.
23. Aloia MS, Arnedt JT, Stepnowsky C, Hecht J, Borrelli B. Predicting treatment adherence in obstructive sleep apnea using principles of behavior change. J Clin Sleep Med 2005; 1: 346-353.
24. Lawsin C, DuHamel K, Weiss A, Rakowski W, Jandorf L. Colorectal cancer screening among low-income African Americans in East Harlem: a theoretical approach to understanding barriers and promoters to screening. J Urban Health 2007; 84: 32-44. (Pubitemid 46147369)
25. Kavookjian J, Berger BA, Grimley DM, Villaume WA, Anderson HM, Barker KN. Patient decision making: strategies for diabetes diet adherence intervention. Res Social Adm Pharm 2005; 1: 389-407. (Pubitemid 44061733)
26. Johnson SS, Driskell MM, Johnson JL, Prochaska JM, Zwick W, Prochaska JO. Efficacy of a transtheoretical model-based expert system for antihypertensive adherence. Dis Manag 2006; 9: 291-301. (Pubitemid 46118289)
27. Johnson SS, Driskell MM, Johnson JL, Dyment SJ, Prochaska JO, Prochaska JM et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag 2006; 9: 102-114.
28. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19: 357-362. (Pubitemid 38916494)
29. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-1378.
30. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509-1510.
31. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986; 101: 524-530.
32. Friedman DS, Hahn SR, Gelb L, Tan J, Shah SN, Kim EE et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma: results from the Glaucoma Adherence and Persistency Study. Ophthalmology 2008; 115(8): 1320-1327, 1327.e1-3
33. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology 1998; 104: 2105-2111. (Pubitemid 30211781)
34. Friedman DS, Quigley HA, Gelb L, Tan J, Margolis J, Shah SN et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci 2007; 48: 5052-5057. (Pubitemid 351260915)
35. Resnicow K, DiIorio C, Soet J et al. Motivational interviewing in medical and public health settings. In Miller W, Rollnick S (eds). Motivational Interviewing: Preparing People for Change, 2nd ed. Guilford Press: New York, 2002, pp 251-269.
36. Resnicow K, DiIorio C, Soet JE, Ernst D, Borrelli B, Hecht J. Motivational interviewing in health promotion: It sounds like something is changing. Health Psychol 2002; 21: 444-451. (Pubitemid 34921077)
37. Britt E, Hudson SM, Blampied NM. Motivational interviewing in health settings: a review. Patient Ed Couns 2004; 53: 147-155. (Pubitemid 38622059)
38. Harland J, White M, Drinkwater C, Chinn D, Farr L, Howel D. The Newcastle exercise project: a randomised controlled trial of methods to promote physical activity in primary care. BMJ 1999; 319: 828-832. (Pubitemid 29445923)
39. Resnicow K, Wallace D, Jackson A, Digirolamo A, Odom E, Wang T et al. Dietary change through Black churches: baseline results and program description of the Eat for Life Trial. J Cancer Ed 2000; 15: 156-163.
40. Glasgow R, Whitlock E, Eakin E, Lichtstein E. A brief smoking cessation intervention for women in low-income Planned Parenthood clinics. Am J Public Health 2000; 90: 786-789. (Pubitemid 30246385)
41. Butler C, Rollnick S, Cohen D, Bachman M, Russell I, Stott N. Motivational consulting vs brief advice for smokers in general practice: A randomized trial. Br J Gen Pract 1999; 49: 611-616. (Pubitemid 29389478)
42. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients. Randomized controlled trial. BMJ 1996; 312: 345-349.
43. Kemp R, Kirov B, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. Br J Psychiatry 1998; 172: 413-419.
44. Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye 2000; 14: 752-756. (Pubitemid 30838323)
45. MacKean JM, Elkington AR. Compliance with treatment of patients with chronic open-angle glaucoma. Br J Ophthalmol 1983; 67: 46-49. (Pubitemid 13172509)
46. Patel SC, Spaeth GL. Compliance in patients prescribed eye drops for glaucoma. Ophthalmic Surg 1995; 26: 233-236.
47. Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther 2002; 18: 401-409. (Pubitemid 37420249)
48. Gelb L, Friedman DS, Quigley HA, Lyon DW, Tan J, Kim EE et al. Physician beliefs and behaviors related to glaucoma treatment adherence: the GAPS study. J Glaucoma 2008, (forthcoming).
49. Quigley HA, Friedman DS, Hahn SR. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data. The Glaucoma Adherence and Persistency Study. Ophthalmology 2007; 114: 1599-1606.